Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2018

View Archived Issues

Blood protein networks linked to complex diseases

Multigene assay constructed to predict late recurrence in ER-positive breast cancer

Suppressive role of exosomal TRIM3 in gastric cancer growth: potential biomarker and therapy target

First patients dosed in phase I/II study of FX-322

Salvensis patents compounds for schistosomiasis

Resverlogix announces seventh positive recommendation for phase III study of apabetalone

Korean researchers divulge new antiviral compounds

Data analysis completed for second cohort in part I of phase I/IIa study of CRV-431

U.S. researchers identify ITGA5 antagonists

NHRI synthesizes new CXCR4 ligands

Sichuan Kelun-Biotech Biopharmaceutical patents FXR agonists

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Plant-derived compound silvestrol inhibits HEV replication with additive effect to ribavirin

FDA expands approval of Orkambi to children 2 to 5 years of age

Researchers present new anti-CRH MAb for AD downstream pathologies

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

DMC recommends early continuation of phase III GENESIS study of BL-8040

Recruitment underway in TaiRx's phase II study of CMV-118 in combination with sorafenib

New sulfonamide is potent anti-breast cancer agent

Aged rhesus monkey shows same pattern of tau pathology as humans

Teneobio and Poseida to use UniDabs to develop CAR-T therapies

New biological target for Alzheimer's identified in BioArctic/Eisai collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...